| Diabetic neuropathy: a position statement by the American Diabetes Association R Pop-Busui, AJM Boulton, EL Feldman, V Bril, R Freeman, RA Malik, ... Diabetes care 40 (1), 136, 2017 | 2404 | 2017 |
| Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial F Ismail-Beigi, T Craven, MA Banerji, J Basile, J Calles, RM Cohen, ... The Lancet 376 (9739), 419-430, 2010 | 1758 | 2010 |
| Diabetic neuropathy EL Feldman, BC Callaghan, R Pop-Busui, DW Zochodne, DE Wright, ... Nature reviews Disease primers 5 (1), 1-18, 2019 | 1292 | 2019 |
| Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management V Spallone, D Ziegler, R Freeman, L Bernardi, S Frontoni, R Pop‐Busui, ... Diabetes/metabolism research and reviews 27 (7), 639-653, 2011 | 1060 | 2011 |
| Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial R Pop-Busui, GW Evans, HC Gerstein, V Fonseca, JL Fleg, BJ Hoogwerf, ... Diabetes care 33 (7), 1578-1584, 2010 | 659 | 2010 |
| Cardiac autonomic neuropathy in diabetes: a clinical perspective R Pop-Busui Diabetes care 33 (2), 434, 2010 | 613 | 2010 |
| Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood D Dabelea, JM Stafford, EJ Mayer-Davis, R D’Agostino, L Dolan, ... Jama 317 (8), 825-835, 2017 | 611 | 2017 |
| Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study CL Martin, JW Albers, R Pop-Busui, DCCT/EDiC research Group Diabetes care 37 (1), 31-38, 2014 | 520 | 2014 |
| Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and … WH Herman, R Pop‐Busui, BH Braffett, CL Martin, PA Cleary, JW Albers, ... Diabetic medicine 29 (7), 937-944, 2012 | 496 | 2012 |
| Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of … JW Albers, WH Herman, R Pop-Busui, EL Feldman, CL Martin, PA Cleary, ... Diabetes care 33 (5), 1090-1096, 2010 | 461 | 2010 |
| Elevated triglycerides correlate with progression of diabetic neuropathy TD Wiggin, KA Sullivan, R Pop-Busui, A Amato, AAF Sima, EL Feldman Diabetes 58 (7), 1634-1640, 2009 | 441 | 2009 |
| Diabetic neuropathy: mechanisms, emerging treatments, and subtypes JW Albers, R Pop-Busui Current neurology and neuroscience reports 14, 1-11, 2014 | 425 | 2014 |
| Diabetic neuropathy and oxidative stress R Pop‐Busui, A Sima, M Stevens Diabetes/metabolism research and reviews 22 (4), 257-273, 2006 | 389 | 2006 |
| Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology … R Pop-Busui, PA Low, BH Waberski, CL Martin, JW Albers, EL Feldman, ... Circulation 119 (22), 2886-2893, 2009 | 384 | 2009 |
| Glucose control and diabetic neuropathy: lessons from recent large clinical trials L Ang, M Jaiswal, C Martin, R Pop-Busui Current diabetes reports 14, 1-15, 2014 | 325 | 2014 |
| Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: SEARCH for diabetes in youth study M Jaiswal, J Divers, D Dabelea, S Isom, RA Bell, CL Martin, DJ Pettitt, ... Diabetes care 40 (9), 1226-1232, 2017 | 310 | 2017 |
| REPLACE-BG: a randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes G Aleppo, KJ Ruedy, TD Riddlesworth, DF Kruger, AL Peters, I Hirsch, ... Diabetes care 40 (4), 538-545, 2017 | 288 | 2017 |
| Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial T Martens, RW Beck, R Bailey, KJ Ruedy, P Calhoun, AL Peters, ... Jama 325 (22), 2262-2272, 2021 | 280 | 2021 |
| Serum urate lowering with allopurinol and kidney function in type 1 diabetes A Doria, AT Galecki, C Spino, R Pop-Busui, DZ Cherney, I Lingvay, ... New England Journal of Medicine 382 (26), 2493-2503, 2020 | 270 | 2020 |
| Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction R Pop-Busui, I Kirkwood, H Schmid, V Marinescu, J Schroeder, D Larkin, ... Journal of the American College of Cardiology 44 (12), 2368-2374, 2004 | 242 | 2004 |
